Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

23.85 +0.09 (+0.38%)
Official Closing Price Updated: 4:10 PM EDT, Sep 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 38,964,204
Open 23.79
Bid (Size) 23.85 (2)
Ask (Size) 23.87 (6)
Prev. Close 23.76
Today's Range 23.64 - 23.86
52wk Range 20.91 - 30.43
Shares Outstanding 5,606,688,356
Dividend Yield 7.21%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
These S&P500 stocks are the most active in today's session
Explore the S&P500 index on Monday and find out which stocks are the most active in today's session. Stay updated with the stocks that are capturing market interest and driving market movements. 
Via Chartmill
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Premier, Inc. (Nasdaq – PINC), Metsera, Inc. (Nasdaq – MTSR), Anywhere Real Estate Inc. (NYSE – HOUS), The ODP Corporation (Nasdaq – ODP)
From Brodsky & Smith LLC
Via GlobeNewswire

Performance

YTD
-10.4%
-10.4%
1 Month
-3.7%
-3.7%
3 Month
-1.6%
-1.6%
6 Month
-5.9%
-5.9%
1 Year
-17.6%
-17.6%

More News

Read More
Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk
Via Benzinga
Topics ETFs
Dow Futures Defy Shutdown Fears: A Deep Dive into Market Resilience
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
Digital Pharma Advances 2026: AI and Patient-Centric Strategies Transform Pharma Marketing
Via PRLog
Topics Artificial Intelligence
Genmab Strikes $8 Billion Deal To Acquire Cancer-Focused Merus
Via Investor's Business Daily
Topics Government
U.S. Government Teeters on Brink of Shutdown: Markets Brace for Uncertainty Amidst Data Blackout Fears
Via MarketMinute
Topics Bonds Economy Government
3 High-Yield Dividend Stocks to Buy Now for a Lifetime of Passive Income
Via The Motley Fool
Topics Artificial Intelligence Economy
Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms
Via Benzinga
Topics Government World Trade
Inside MrBeast's $5 Billion Generosity Machine — and the Hidden Costs Behind It
Via Benzinga
Why Pfizer's Post-COVID Future Looks Brighter Than Ever
Via The Motley Fool
BridgeBio, Up 80% This Year, Just Unveiled Promising News For Its Pfizer Rival
Via Investor's Business Daily
Down 55%, Should You Buy the Dip on Pfizer?
Via The Motley Fool
Topics Intellectual Property
5 Dividend Powerhouses to Buy and Never Sell
Via The Motley Fool
Topics Intellectual Property
Johnson & Johnson's Hypothetical Rally: A Look at Potential 2025 Valuation Drivers
Via MarketMinute
Topics Economy Intellectual Property
Abbott India Limited: A Deep Dive into its Robust Forecast and Valuation Outlook Amidst a Thriving Indian Pharma Market
Via MarketMinute
Topics Economy Intellectual Property
US Government Braces for Unprecedented Shutdown: Economic Fallout Looms as Deadline Nears
Via MarketMinute
Topics Economy Government Workforce
Is Pfizer Stock a Buy After Its $5 Billion GLP-1 Bet?
Via The Motley Fool
3 Magnificent Stocks Under $100 to Buy Right Now
Via The Motley Fool
Pfizer is Locking in New Growth Through a New Acquisition
Via MarketBeat
Topics Artificial Intelligence
Pfizer Faces Court Over Depo-Provera Brain Tumor Claims
Via Benzinga
Trump's 100% Drug Tariffs 'A Meaningful Commercial Hit' For Americans, But 'Loopholes' Could Blunt Impact, Says Analyst
Via Benzinga
Topics Government World Trade
Did Pfizer Just Give Investors 7 Billion Reasons to Buy Its Stock?
Via The Motley Fool
Topics Intellectual Property
Trump's 100% Pharmaceutical Tariff: The $270 Billion Manufacturing War That Could Reshape Your Medicine Cabinet
Via Benzinga
Topics Government World Trade
2 Top Passive Income Stocks to Buy Now
Via The Motley Fool
Topics Bonds Economy Lawsuit

Frequently Asked Questions

Is Pfizer publicly traded?
Yes, Pfizer is publicly traded.
What exchange does Pfizer trade on?
Pfizer trades on the New York Stock Exchange
What is the ticker symbol for Pfizer?
The ticker symbol for Pfizer is PFE on the New York Stock Exchange
What is the current price of Pfizer?
The current price of Pfizer is 23.85
When was Pfizer last traded?
The last trade of Pfizer was at 09/29/25 04:10 PM ET
What is the market capitalization of Pfizer?
The market capitalization of Pfizer is 133.72B
How many shares of Pfizer are outstanding?
Pfizer has 134B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.